Literature DB >> 20367396

Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer?

Einar Servoll1, Thorstein Saeter, Ljiljana Vlatkovic, Jahn Nesland, Gudmund Waaler, Hans Olav Beisland.   

Abstract

OBJECTIVE: The presence of a tertiary Gleason grade (TGG) pattern 4 or 5 in radical prostatectomy (RP) specimens has been reported with adverse pathology and a higher biochemical relapse rate after RP. This study investigated the impact of a TGG pattern 4 or 5 on biochemical and pathological outcome in men operated with RP.
MATERIAL AND METHODS: The study reviewed 151 consecutive cases treated at the hospital between 1985 and 2006; 148 were included in the study. All prostatectomy specimens were re-examined by a genitourinary pathologist and among others parameters the presence of TGG pattern 4 or 5 was recorded. The hospital files were examined retrospectively for clinical follow-up data. Prostate-specific antigen (PSA) relapse was defined as two subsequent rising measurements above 0.20 ng/ml. The influence of a TGG pattern 4 or 5 on prognosis was assessed in a Cox proportional hazards regression model controlling for pathological stage, surgical margin (SM) status, seminal vesicle invasion (SVI) and extraprostatic extension (EPE).
RESULTS: Fifty-six patients (38%) experienced PSA relapse during follow-up. Twenty-one patients (58%) with a TGG pattern 4 or 5 had a biochemical relapse compared with 35 patients (31%) without TGG pattern 4 or 5. In the Cox regression model, TGG pattern 4 or 5 was an independent predictor of biochemical failure (p = 0.020).
CONCLUSIONS: In patients undergoing RP the presence of a TGG pattern 4 or 5 is an independent predictor for biochemical relapse. Consequently, the RP specimens should routinely be investigated for TGG pattern 4 or 5.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367396     DOI: 10.3109/00365591003720283

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Authors:  Hillary M Ross; Oleksandr N Kryvenko; Janet E Cowan; Jeffry P Simko; Thomas M Wheeler; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

2.  Fast hybrid optomechanical scanning photoacoustic remote sensing microscopy for virtual histology.

Authors:  Brendon S Restall; Brendyn D Cikaluk; Matthew T Martell; Nathaniel J M Haven; Rohan Mittal; Sveta Silverman; Lashan Peiris; Jean Deschenes; Benjamin A Adam; Adam Kinnaird; Roger J Zemp
Journal:  Biomed Opt Express       Date:  2021-12-02       Impact factor: 3.732

3.  Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.

Authors:  Chirag Doshi; Michael Vacchio; Kristopher Attwood; Christine Murekeyisoni; Diana C Mehedint; Shervin Badkhshan; Gissou Azabdaftari; Norbert Sule; Khurshid A Guru; James L Mohler; Eric C Kauffman
Journal:  Prostate       Date:  2016-02-16       Impact factor: 4.104

4.  Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.

Authors:  C Athena Aktipis; Virginia S Y Kwan; Kathryn A Johnson; Steven L Neuberg; Carlo C Maley
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

Review 5.  Grading of prostatic adenocarcinoma: current state and prognostic implications.

Authors:  Jennifer Gordetsky; Jonathan Epstein
Journal:  Diagn Pathol       Date:  2016-03-09       Impact factor: 2.644

6.  Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Monique J Roobol; Jozien Helleman; Geert J L H van Leenders
Journal:  Histopathology       Date:  2020-04       Impact factor: 5.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.